Articles Tagged With:
-
White House Targets Long COVID with Major Interagency Initiative
The Biden administration has launched a major initiative to better understand and treat long COVID, which manifests as brain fog, fatigue, and a panoply of other lingering symptoms in those with SARS-CoV-2.
-
OSHA Finalizing COVID-19 Rule in Healthcare Settings
Under the CDC's current guidance for healthcare workers, many requirements for those workers are triggered based on the level of community transmission of COVID-19. Such an approach would create the flexibility many have been calling for, which have come with the warning that requirements set in regulatory stone could quickly be outdated by the changing nature of the pandemic.
-
FDA Struggles to Find Way Forward on COVID-19 Vaccine
Vaccine advisors to the Food and Drug Administration face a tight timeline and a host of unknowns as they try to prepare for an expected winter surge of COVID-19, all the while acknowledging that any plan forward could be dashed by the emergence of a new variant of the pandemic virus.
-
Project Firstline: Teaching the ‘Why’ of Infection Prevention
In paring down its isolation guidelines, the CDC is moving in step with its Project Firstline initiative — an ambitious effort to teach all healthcare workers the basics of infection prevention.
-
CDC Revising Isolation Guidelines; Revisiting Airborne, Droplet Spread
Infection prevention leaders welcomed the CDC's plan to revise its 2007 patient isolation guideline, which will include dropping the current 206-page “textbook” approach for a leaner, more user-friendly document that healthcare workers can easily access and understand.
-
Mimics of ST-Elevation Myocardial Infarction (STEMI)
It is important for emergency medicine physicians to have an understanding of the differential diagnosis of ST-segment elevation.
-
Infectious Disease Alert Updates
Recovering from Critical COVID; Oral and Anal Transmission of Syphilis
-
A Case of Monkeypox in a Returned Traveler
The arrival of a traveler from Nigeria to the United States with monkeypox infection, which was quickly recognized, led to a massive public health response investigating exposed individuals, but no secondary cases were detected.
-
Maribavir (Livtencity)
The FDA approved maribavir as the first drug to treat adult and pediatric patients with post-transplant cytomegalovirus infections that do not respond to currently available antiviral treatment.
-
Persistent Inflammation and Post-COVID Syndrome
Ongoing inflammation may contribute to long COVID.